Skip to main content
Have a personal or library account? Click to login
Ethosuximide vs Valproate Long-term Remission of Absence Epilepsy Cover

Ethosuximide vs Valproate Long-term Remission of Absence Epilepsy

Open Access
|Jun 2014

Abstract

Investigators from the Epilepsy Center, Lurie Children's Hospital of Chicago, and Yale School of Medicine, New Haven, CT, examined the possible association between long-term seizure outcome of childhood absence epilepsy (CAE) and the initial treatment with ethosuximide (ESM) or valproic acid (VPA).
Language: English
Page range: 43 - 44
Published on: Jun 1, 2014
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services

© 2014 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.